Epidemiologist stresses COVID-19 pathophysiologic research
chinadaily.com.cn |
Updated: 2020-03-19 08:00
Share
Share - WeChat
More research should be done on the overreaction of the immune response in COVID-19 disease, said Zhong Nanshan, China's leading epidemic control expert, in a recent video talk.
Zhong also noted that once the patients deteriorate, the survival rate is pretty low, as some of the pathophysiologic characteristics are different from usual cases of ARDS, or acute respiratory distress syndrome.
Zhong shared China's experience in the fight against the coronavirus with Dr. Anita Simonds, the president-elect of the European Respiratory Society, in an online conversation earlier this month.
- Foreigners check-in to China for hospital expertise
- Forum underlines cross-Strait exchanges
- China, Uruguay vow to deepen ties
- Hunan achieves record grain output in 2025
- Thai students to train in China as universities expand high-speed rail cooperation
- China unveils world's fastest full-size humanoid robot
